Associations Between Estimated Pulse Wave Velocity and Five-Year All-Cause Mortality in Patients with Atherosclerotic Cardiovascular Disease with and without Standard Modifiable Risk Factors: Evidence From NHANES 1999-2016
Xicong Li,Yubiao Chen,Baiyun Liu,Mingyuan Ye,Bei Liu,Lifei Lu,Ruiwei Guo
DOI: https://doi.org/10.2147/clep.s457054
2024-05-29
Clinical Epidemiology
Abstract:Xicong Li, 1, 2, &ast Yubiao Chen, 3, &ast Baiyun Liu, 3, &ast Mingyuan Ye, 4 Bei Liu, 2 Lifei Lu, 3 Ruiwei Guo 2 1 Department of Cardiovascular, Kunming Medical University, Kunming, Yunnan, People's Republic of China; 2 Department of Cardiovascular, 920th Hospital of Joint Logistics Support Force, Chinese People's Liberation Army (PLA), Kunming, Yunnan, People's Republic of China; 3 Department of Respiratory Medicine, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, People's Republic of China; 4 Department of Otolaryngology, Zhuhai Maternity and Child Health Hospital, Zhuhai, Guangdong, People's Republic of China &astThese authors contributed equally to this work Correspondence: Lifei Lu, Department of Respiratory Medicine, State Key Laboratory of Respiratory Disease, National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, People's Republic of China, Email Ruiwei Guo, Department of Cardiovascular, 920th Hospital of Joint Logistics Support Force, PLA, Kunming, Yunnan, People's Republic of China, Email Aim: The study aimed to analyze the associations between estimated pulse wave velocity (ePWV) and 5-year mortality in atherosclerotic cardiovascular disease (ASCVD) patients with and without standard modifiable risk factors (SMuRFs), which included smoking status, hypertension, diabetes, and hypercholesterolemia. Methods: The present retrospective cohort study utilized data from the National Health and Nutrition Examination Survey (NHANES) between 1999 and 2016. Patients with ASCVD who completed both the questionnaire survey and serum testing were included. Patients were categorized into the ≥ 1 SMuRF group if they had at least one SMuRF, while those without any SMuRFs were classified into the SMuRF-less group. The ePWV, which was calculated using the age and mean blood pressure, was evenly divided into three categories: low (Q1), medium (Q2), and high (Q3). Multivariable weighted Cox proportional-hazard regression analyses were utilized to explore the risk factors associated with 5-year mortality in patients with and without SMuRFs. And restricted cubic spline curve (RCS) was used to assess their nonlinear correlation. Results: A total of 1901 patients with ASCVD were included in the study. For the patients in ≥ 1 SMuRF group, the Q3 group included patients who were older, with a higher proportion of males, more comorbidities, and a lower body mass index than the Q1 group (P< 0.05). The Cox proportional-hazard regression model results revealed, the Q3 group had a higher risk of 5-year mortality than the Q1 group [hazard ratio (HR) 4.30, 95% confidence interval (CI) (2.66, 6.95), P< 0.001]. RCS demonstrated a linear trend between high level of ePWV and decreased risks of mortality. Similar results were observed in the SMuRF-less group [HR 10.62, 95% CI (1.22, 92.06), P=0.032]. Conclusion: A high level of ePWV signified a higher risk of 5-year mortality in ASCVD patients with and without SMuRFs. Keywords: atherosclerotic cardiovascular disease, standard modifiable risk factors, estimated pulse wave velocity, all-cause mortality Atherosclerotic cardiovascular disease (ASCVD) is caused by plaque buildup in arterial walls and refers to conditions that include coronary artery disease (CAD) and stroke, and it remains a leading cause of the global burden of morbidity and mortality. 1–3 The prevention and treatment of cardiovascular disease has always been in the spotlight. The Framingham Heart Study (FHS) first described four standard modifiable risk factors (SMuRFs), including smoking status, hypertension, diabetes, and hypercholesterolemia. 4 This milestone research has enhanced primary healthcare for patients with ASCVD, emphasizing the identification and management of SMuRFs as effective measures for improving prognosis. 5 In 2021, modifiable risk factors recommended by the European Society of Cardiology (ESC) in patients with ASCVD were defined as high nonHDL-cholesterol, high blood pressure, cigarette smoking, and diabetes. The systematic coronary risk estimation 2 (SCORE 2) and SCORE 2-older persons risk charts have been designed to assess the risk of fatal and non-fatal (myocardial infarction, stroke) cardiovascular disease, -Abstract Truncated-
public, environmental & occupational health